LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$3.60
+2.71%
Mkt Cap $109.97M
Analyst Ratings
Buy
6
Hold
2
Sell
0
Price Target (8 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+39.1%
Consensus $5.00 vs current $3.60
NASDAQ·Healthcare·Biotechnology
$3.60
+2.71%
Mkt Cap $109.97M
Buy
6
Hold
2
Sell
0
Price Target (8 analysts)
$5.00
Range $5.00 – $5.00
+39.1%
Consensus $5.00 vs current $3.60